Zeo ScientifiX ZEOX
OTC ZEOX
$1.42 +0.07 (+5.19%)
At close: Aug 20, 2026 · 4:00 PM EDT

Zeo ScientifiX (ZEOX) Cash from Discontinued Operations (2015 - 2016)

Zeo ScientifiX (ZEOX) posted quarterly Cash from Discontinued Operations of 13620.0 for Q4 2016, up 112.66% year-over-year from 6404.66 in Q4 2015, and up 194.05% quarter-over-quarter from 14482.0 in Q3 2016.

Zeo ScientifiX (ZEOX) Cash from Discontinued Operations (2015 - 2016) Analysis & Trends

Zeo ScientifiX's Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 13620.0 for Q4 2016.

  • In Q4 2016, Cash from Discontinued Operations rose 112.66% year-over-year to 13620.0; the TTM figure through Oct 2016 stood at 2098.0 (up 102.76% YoY), while the FY2016 annual figure was 2098.0, up 102.76% from the prior year.
  • Cash from Discontinued Operations for Q4 2016 stood at 13620.0, up from 14482.0 in the prior quarter.
  • The five-year high for Cash from Discontinued Operations was 19049.0 in Q3 2015, with the low at 107603.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Zeo ScientifiX 10.51 Mn 8.67 Mn 2.06 Mn -

Historic Data

Download Data
DateValue
Oct 31, 2016 13,620.00
Oct 31, 2016 13,620.00
Jul 31, 2016 -14,482.00
Jul 31, 2016 -14,482.00
Apr 30, 2016 1.00
Apr 30, 2016 1.00
Jan 31, 2016 2,959.00
Jan 31, 2016 2,959.00
Oct 31, 2015 -107,603.00
Oct 31, 2015 -107,603.00
Jul 31, 2015 19,049.00
Jul 31, 2015 19,049.00
Apr 30, 2015 11,811.00
Apr 30, 2015 11,811.00
Jan 31, 2015 808.00
Jan 31, 2015 808.00